Author

A. Eden Cruikshank

University of North Carolina at Chapel HillORCID 0000-0002-7148-9355Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Assay:CUT&Tag· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Baggio EvangelistaiD· 1 shared Christopher I. LiiD· 1 shared Douglas H. PhanstieliD· 1 shared Gavin HaiD· 1 shared Hyejung WoniD· 1 shared Ivana Yoseli QuirogaiD· 1 shared Joey V. RagusaiD· 1 shared Jui‐Heng TsengiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Baggio EvangelistaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-omic Profiling of Recurrence Risk Across Breast Cancer Subtypes

A. Eden Cruikshank, Pooja Chandra, Christopher I. Li, Gavin Ha

This study identifies subtype-specific molecular and immune features associated with recurrence risk in breast cancer using multi-omic analysis of 340 tumors and validates predictive models in an external cohort.

medRxiv · Jul 14, 2026 · PreprintGenetic & Genomic Medicine

Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems

Ivana Yoseli Quiroga, A. Eden Cruikshank, Kathleen S Metz Reed, Marielle L. Bond, Baggio Evangelista, Jui‐Heng Tseng, Joey V. Ragusa, Rick B. Meeker, Hyejung Won, Sarah Cohen, T.J. Cohen, Douglas H. Phanstiel

The paper assesses the transcriptional response of in vitro innate immune cell models to synthetic amyloid beta and finds no robust response, but identifies LPS and INFγ as better activators of microglia-like cells.

Journal of Neuroinflammation · Apr 23, 2022Peer-reviewedNeuroscience